Cobimetinib: First Global Approval-Reference-Cited by-同舟云学术

Cobimetinib: First Global Approval

Published:2015-10 Issue:15 Volume:75 Page:1823-1830
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Garnock-Jones Karly P.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-015-0477-8.pdf

Reference28 articles.

1. Sullivan R, LoRusso P, Boerner S, et al. Achievements and challenges of molecular targeted therapy in melanoma. Am Soc Clin Oncol Educ Book. 2015:177–86. doi: 10.14694/EdBook_AM.2015.35.177 .

2. Akinleye A, Furqan M, Mukhi N, et al. MEK and the inhibitors: from bench to bedside. J Hematol Oncol. 2013;6(1):27.

3. Rahman A. Vemurafenib and cobimetinib in BRAF-mutated melanoma. Lancet Oncol. 2014;15(12):e535.

4. Exelixis. Exelixis (EXEL) announces first regulatory approval of cobimetinib in Switzerland [media release]. 27 Aug 2015. http://www.biospace.com/ .

5. Roche Pharma. Cotellic® (cobimetinib tablets): Swiss prescribing information. 2015. https://compendium.ch . Accessed 4 Sep 2015.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the RAS upstream and downstream signaling pathway for cancer treatment;European Journal of Pharmacology;2024-09

2. Bazedoxifene attenuates dextran sodium sulfate-induced colitis in mice through gut microbiota modulation and inhibition of STAT3 and NF-κB pathways;European Journal of Pharmacology;2024-07

3. Discovery of a CK2α′-Biased ATP-Competitive Inhibitor from a High-Throughput Screen of an Allosteric-Inhibitor-Like Compound Library;ACS Chemical Neuroscience;2024-06-22

4. Pancreatic Cancer: A Review on Pathophysiology, Naturopathy, Clinical Treatment and Outcomes;Current Cancer Therapy Reviews;2024-05

5. Synthesis and Functionalization of Azetidine‐Containing Small Macrocyclic Peptides;Chemistry – A European Journal;2024-04-09